- LCTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Lineage Cell Therapeutics (LCTX) S-3Shelf registration
Filed: 6 Apr 17, 12:00am
Years Ended December 31, | ||||||||||||||||||||
2016 | 2015 | 2014 | 2013 | 2012 | ||||||||||||||||
Computation of Earnings: | (In Thousands) | |||||||||||||||||||
Pretax loss before equity method investees | $ | (11,069 | ) | $ | (62,615 | ) | $ | (51,155 | ) | $ | (56,190 | ) | $ | (25,306 | ) | |||||
Add: | ||||||||||||||||||||
Interest expense | 1,043 | 377 | 64 | 3 | - | |||||||||||||||
Amortization of debt discount | 448 | 264 | 56 | - | - | |||||||||||||||
Estimated interest component of rent expense(1) | 508 | 693 | 654 | 516 | 378 | |||||||||||||||
Earnings as adjusted | $ | (9,070 | ) | $ | (61,281 | ) | $ | (50,381 | ) | $ | (55,671 | ) | $ | (24,928 | ) | |||||
Computation of fixed charges: | ||||||||||||||||||||
Interest expense | $ | 1,043 | $ | 377 | $ | 64 | $ | 3 | $ | - | ||||||||||
Amortization of debt discount | 448 | 264 | 56 | - | - | |||||||||||||||
Estimated interest component of rent expense | 508 | 693 | 654 | 516 | 378 | |||||||||||||||
Total fixed charges | $ | 1,999 | $ | 1,334 | $ | 774 | $ | 519 | $ | 378 | ||||||||||
Dividends on preferred shares | $ | - | $ | 415 | $ | 87 | $ | - | $ | - | ||||||||||
Combined fixed charges and preferred stock dividends | $ | 1,999 | $ | 1,749 | $ | 861 | $ | 519 | $ | 378 | ||||||||||
Deficiency in earnings required to cover fixed charges | $ | (11,069 | ) | $ | (62,615 | ) | $ | (51,155 | ) | $ | (56,190 | ) | $ | (25,306 | ) | |||||
Ratio of earnings to fixed charges(2) | - | - | - | - | - | |||||||||||||||
Deficiency in earnings required to cover combined fixed charges and preferred stock dividends | $ | (11,069 | ) | $ | (63,030 | ) | $ | (51,242 | ) | $ | (56,190 | ) | $ | (25,306 | ) | |||||
Ratio of earnings to fixed changes and preferred dividends(3) | - | - | - | - | - |